EGFR and glioblastoma: Primary glioblastomas exhibit frequent EGFR amplification, homozygous deletion of CDKN2A and p14ARF, CDK4 amplification, MDM2 or MDM4 amplification, RB1 mutation/homozygous deletion, monosomy 10 and PTEN mutation [21–25].